2020

20.01.2020 – Straumann Holding AG

Camila Finzi appointed Head of Straumann’s fast-growing orthodontics business and Member of the Executive Management

Camila Finzi appointed Head of Straumann’s fast-growing orthodontics business and Member of the Executive Management

  • Top leadership skills and experience brought in from Alcon and Novartis
  • Straumann’s orthodontics business now organized into a separate global unit, reflecting its strategic importance and high potential

Basel, 20 January 2020 – The Straumann Group is pleased to announce the appointment of Camila Finzi as Head of its fast-growing orthodontics business and Member of the Executive Management. She joins the Group today and is based at its ClearCorrect headquarters in Round Rock, Texas. In view of the significant potential and strategic importance of esthetic dentistry, the Group has organized orthodontics into a separate dedicated business unit, which incorporates the ClearCorrect, Smyletec and Geniova clear-aligner brands as well as the recently acquired Bay Materials thermoplastics business. With ClearCorrect entering new markets, the company is rapidly building up sales, distribution and production infrastructure.

Straumann Group CEO Guillaume Daniellot commented, “Camilla’s leadership skills, business acumen, operational experience and commercial expertise in medical devices are precisely the qualities we need in order to develop our orthodontic business and drive further dynamic growth. In addition, her experience of highly successful innovative global corporations will enrich our leadership team”.

Camilla Finzi joins Straumann from Alcon, the largest eye-care device company in the world. In her most recent role, she was responsible for the Latin America and Caribbean Region, where she has a strong track record in product launches and business expansion. From 2004 to 2013 she worked for Alcon’s parent company, Novartis, rising through managerial positions of increasing responsibility in Marketing and Sales to Business-Unit and Regional leadership. Prior to joining Novartis, she spent four years at Pfizer – initially in Finance, and subsequently in senior pharmaceutical product management. The first six years of her career were in Finance at Cargill and Arthur Andersen. Mrs Finzi is Brazilian and holds a bachelors’ degree in economics from the Fundação Armando Álvares Penteado University in São Paulo. She also has an MBA from Fundação Dom Cabral Business School and completed an Executive Education program at Harvard University.

About Straumann

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Neodent, Medentika, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.

Headquartered in Basel, Switzerland, the Group currently employs approx. 7600 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland.

Phone: +41 (0)61 965 11 11 / Fax: +41 (0)61 965 11 01

Homepage: www.straumann-group.com

Contacts:

Corporate Communications

Mark Hill: +41 (0)61 965 13 21

Jana Erdmann: +41 (0)61 965 12 39

e-mail: corporate.communication@straumann.com

Investor Relations

Marcel Kellerhals: +41 (0)61 965 17 51

e-mail: investor.relations@straumann.com

Disclaimer

This release contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expressed or implied in this release. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise.

# # #


fermer